Latest Board Changes News

Findi Limited reported a 51% surge in revenue to $49.26 million for the half year ended 30 September 2025, driven by key acquisitions in India. However, the company posted a significant operating loss of $24.65 million amid integration costs and faces material uncertainty over its going concern status.

Pathkey.AI has secured A$2.5 million through a placement and launched a nearly A$1 million rights issue to fund expansion of its AI-driven TrialKey platform and pursue strategic acquisitions, alongside key board changes.

Redivium Limited is progressing recapitalisation efforts and revising its UK lithium-ion battery recycling project plans amid ongoing ASX suspension. The company is engaging Australian investors to support reinstatement and updating feasibility studies following site changes.

Maggie Beer Holdings reveals strategic progress in its 2025 AGM, focusing on operational simplification, financial stability, and targeted growth for its iconic brands.

Aroa Biosurgery reported a 14% rise in product sales to NZ$44.6 million for the half-year ended September 2025, driven by strong growth in its Myriad portfolio. The company also posted a normalised EBITDA profit and reaffirmed its FY26 revenue and profit guidance.

The Star Entertainment Group has secured crucial regulatory approvals to convert a $300 million strategic investment by Bally’s Corporation and Investment Holdings into equity, setting the stage for board changes and a path toward financial recovery.

Reece Limited reported a modest revenue decline and earnings pressure in FY25 amid challenging markets but reinforced its long-term growth strategy with a significant share buyback and board renewal. Early FY26 trading shows sales growth driven by network expansion despite ongoing cost pressures.

Alterity Therapeutics announces significant board changes, including the retirement of founding chairman Geoffrey Kempler and appointment of CEO Dr David Stamler as Managing Director, aligning leadership with its Phase 3 clinical ambitions.

Mastermyne’s FY2025 AGM reveals resilience amid sector headwinds, operational disruptions, and legal proceedings, while positioning for growth with new leadership and contracts.

Charter Hall Group reported solid FY25 results with 7.4% growth in operating earnings per security and upgraded its FY26 earnings guidance to 95 cents, reflecting robust equity inflows and tenant demand. The company also highlighted significant sustainability progress and board changes at its 2025 AGM.

Aspermont Limited's trading suspension has been lifted following a key announcement about new board appointments, signaling a fresh chapter for the media publisher.

Aspermont Limited has appointed John Stark and David Straface as interim directors, reinforcing its board with seasoned insiders during a pivotal growth phase focused on data and intelligence services for global resource sectors.